{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:32:09Z","timestamp":1761921129618},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,25]]},"DOI":"10.7759\/cureus.40920","type":"journal-article","created":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T10:43:52Z","timestamp":1687689832000},"source":"Crossref","is-referenced-by-count":2,"title":["Rare Sensory Ataxic Variant of Guillain-Barre Syndrome: A Case Report"],"prefix":"10.7759","author":[{"given":"Pavithera","family":"Packiyarajah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.T","family":"Sundaresan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.S.M","family":"Nusair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.22298","article-title":"Sensory Guillain-Barr\u00e9 syndrome and related disorders: an attempt at systematization","volume":"45","author":"Uncini A","year":"2012","unstructured":"Uncini A, Yuki N. Sensory Guillain-Barr\u00e9 syndrome and related disorders: an attempt at systematization. Muscle Nerve. 2012, 45:464-70. 10.1002\/mus.22298","journal-title":"Muscle Nerve"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410090703","article-title":"Diagnostic considerations in Guillain-Barr\u00e9 syndrome","volume":"9 Suppl","author":"Asbury AK","year":"1981","unstructured":"Asbury AK. Diagnostic considerations in Guillain-Barr\u00e9 syndrome. Ann Neurol. 1981, 9 Suppl:1-5. 10.1002\/ana.410090703","journal-title":"Ann Neurol"},{"key":"ref3","article-title":"Sensory Guillain-Barr\u00e9 syndrome","volume":"56","author":"Shin JO","year":"2001","unstructured":"Shin JO, LaGanke C, Claussen GC. Sensory Guillain-Barr\u00e9 syndrome. Neurology. 2001, 56:82-6.","journal-title":"Neurology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20100","article-title":"Clinical features and pathophysiological basis of sensory neuronopathies (ganglionopathies)","volume":"30","author":"Kuntzer T","year":"2004","unstructured":"Kuntzer T, Antoine JC, Steck AJ. Clinical features and pathophysiological basis of sensory neuronopathies (ganglionopathies). Muscle Nerve. 2004, 30:255-68. 10.1002\/mus.20100","journal-title":"Muscle Nerve"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/873587","article-title":"Sensory neuronopathy and autoimmune diseases","volume":"2012","author":"Martinez AR","year":"2012","unstructured":"Martinez AR, Nunes MB, Nucci A, Fran\u00e7a MC Jr. Sensory neuronopathy and autoimmune diseases. Autoimmune Dis. 2012, 2012:873587. 10.1155\/2012\/873587","journal-title":"Autoimmune Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000203343.96062.ea","article-title":"Does sensory Guillain-Barr\u00e9 syndrome exist without any abnormalities in motor nerve conduction?","volume":"66","author":"Lee SS","year":"2006","unstructured":"Lee SS, Lee SH. Does sensory Guillain-Barr\u00e9 syndrome exist without any abnormalities in motor nerve conduction?. Neurology. 2006, 66:947-8. 10.1212\/01.wnl.0000203343.96062.ea","journal-title":"Neurology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/tmi.13181","article-title":"Systematic review of factors associated with the development of Guillain-Barr\u00e9 syndrome 2007-2017: what has changed?","volume":"24","author":"Wachira VK","year":"2019","unstructured":"Wachira VK, Peixoto HM, de Oliveira MR. Systematic review of factors associated with the development of Guillain-Barr\u00e9 syndrome 2007-2017: what has changed?. Trop Med Int Health. 2019, 24:132-42. 10.1111\/tmi.13181","journal-title":"Trop Med Int Health"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3329\/jhpn.v28i6.6602","article-title":"Quantifying the association between Campylobacter infection and Guillain-Barr\u00e9 syndrome: a systematic review","volume":"28","author":"Poropatich KO","year":"2010","unstructured":"Poropatich KO, Walker CL, Black RE. Quantifying the association between Campylobacter infection and Guillain-Barr\u00e9 syndrome: a systematic review. J Health Popul Nutr. 2010, 28:545-52. 10.3329\/jhpn.v28i6.6602","journal-title":"J Health Popul Nutr"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2009191","article-title":"Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2","volume":"382","author":"Toscano G","year":"2020","unstructured":"Toscano G, Palmerini F, Ravaglia S, et al.. Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2. N Engl J Med. 2020, 382:2574-6. 10.1056\/NEJMc2009191","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcab296","article-title":"A case of sensory ataxic Guillain-Barr\u00e9 syndrome with immunoglobulin G anti-GM1 antibodies following the first dose of mRNA COVID-19 vaccine BNT162b2 (Pfizer)","volume":"115","author":"Fukushima T","year":"2022","unstructured":"Fukushima T, Tomita M, Ikeda S, Hattori N. A case of sensory ataxic Guillain-Barr\u00e9 syndrome with immunoglobulin G anti-GM1 antibodies following the first dose of mRNA COVID-19 vaccine BNT162b2 (Pfizer). QJM. 2022, 115:25-7. 10.1093\/qjmed\/hcab296","journal-title":"QJM"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(07)70130-8","article-title":"A clinical prognostic scoring system for Guillain-Barr\u00e9 syndrome","volume":"6","author":"van Koningsveld R","year":"2007","unstructured":"van Koningsveld R, Steyerberg EW, Hughes RA, Swan AV, van Doorn PA, Jacobs BC. A clinical prognostic scoring system for Guillain-Barr\u00e9 syndrome. Lancet Neurol. 2007, 6:589-94. 10.1016\/S1474-4422(07)70130-8","journal-title":"Lancet Neurol"},{"key":"ref12","article-title":"20235Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barr\u00e9 syndrome. Plasma Exchange\/Sandoglobulin Guillain-Barr\u00e9 Syndrome Trial Group","volume":"349","author":"Randomised trial of plasma exchange","year":"1997","unstructured":"Randomised trial of plasma exchange, intravenous immunoglobulin, and ... [Internet]. [cited. 20235Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barr\u00e9 syndrome. Plasma Exchange\/Sandoglobulin Guillain-Barr\u00e9 Syndrome Trial Group. Lancet. 1997, 349:225-30.","journal-title":"Lancet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/163618-rare-sensory-ataxic-variant-of-guillain-barre-syndrome-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:04:08Z","timestamp":1707509048000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/163618-rare-sensory-ataxic-variant-of-guillain-barre-syndrome-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,25]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.40920","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,25]]}}}